Drug intelligence / Profile preview

prothrombin complex concentrate

Development stage
Unknown
Lead developer
CSL Behring
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Four-factor prothrombin complex concentrate (4F-PCC) is a biologic, plasma-derived blood product containing the four vitamin K-dependent coagulation factors: Factor II (prothrombin), Factor VII, Factor IX, and Factor X, along with anticoagulant proteins C and S. It is primarily used for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (e.g., warfarin) therapy in adult patients with acute major bleeding or those needing urgent surgery or invasive procedures. Unlike three-factor PCCs, 4F-PCC contains therapeutic amounts of Factor VII, allowing for more rapid and effective normalization of the International Normalized Ratio (INR). Marketed under brand names such as Kcentra and Beriplex, it acts by directly replacing the depleted clotting factors, bypassing the need for vitamin K-mediated synthesis which takes significantly longer. In clinical practice, it is often preferred over fresh frozen plasma (FFP) due to its smaller infusion volume, faster administration, and lack of requirement for blood type matching.

Brand names
KcentraBeriplexConfidexOctaplexCofact
Other names
four-factor prothrombin complex concentrate4F-PCChuman prothrombin complex concentrate
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on prothrombin complex concentrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prothrombin complex concentrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call